ACADIA PHARMACEUTICALS INC (ACAD) › Operating IncomeACADIA PHARMACEUTICALS INC (ACAD) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: -$45.47M2010: $15.09M2011: -$22.85M2012: -$20.89M2013: -$38.30M2014: -$93.23M2015: -$164.61M2016: -$272.81M2017: -$292.41M2018: -$247.44M2019: -$246.54M2020: -$286.59M2021: -$170.44M2022: -$223.60M2023: -$73.38M2024: $230.79M2025: $104.81M$104.81M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$104.81M-54.6%2024$230.79M+414.5%2023-$73.38M+67.2%2022-$223.60M-31.2%2021-$170.44M+40.5%2020-$286.59M-16.2%2019-$246.54M+0.4%2018-$247.44M+15.4%2017-$292.41M-7.2%2016-$272.81M-65.7%2015-$164.61M-76.6%2014-$93.23M-143.4%2013-$38.30M-83.4%2012-$20.89M+8.6%2011-$22.85M-251.4%2010$15.09M+133.2%2009-$45.47M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share